Evidence map›Paper›PMID 39282078›Full record

ArticleMolecular therapy. Methods & clinical development2024

Auto-expansion of

Hongjie Wang, Aphrodite Georgakopoulou, Evangelos Nizamis, Ka Wai Mok, Raïssa Eluère, Robert A Policastro, Paul N Valdmanis, André Lieber

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular therapy. Methods & clinical development, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Molecular therapy. Advances · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hongjie WangUniversity of Washington, Department of Medicine, Division of Medical Genetics, Seattle, WA 98195, USA.
Aphrodite GeorgakopoulouUniversity of Washington, Department of Medicine, Division of Medical Genetics, Seattle, WA 98195, USA.
Evangelos NizamisUniversity of Washington, Department of Medicine, Division of Medical Genetics, Seattle, WA 98195, USA.
Ka Wai MokEnsoma, Inc., Boston, MA, USA.
Raïssa EluèreEnsoma, Inc., Boston, MA, USA.
Robert A PolicastroEnsoma, Inc., Boston, MA, USA.
Paul N ValdmanisUniversity of Washington, Department of Medicine, Division of Medical Genetics, Seattle, WA 98195, USA.
André LieberUniversity of Washington, Department of Medicine, Division of Medical Genetics, Seattle, WA 98195, USA.

Funding

In Vivo Hematopoietic Stem Cell Gene Therapy of Beta-Thalassemia and Sickle Cell DiseaseR01HL130040 · NHLBI · UNIVERSITY OF WASHINGTON · PI LIEBER, ANDRE MICHAEL · 2016 to 2024
$4.3M
TRANSFERRING BEHAV RESEARCH INTO NURSING HOME PRACTICER01AG017430 · NIA · EMORY UNIVERSITY · PI OUSLANDER, JOSEPH G. · 1999 to 2003
$2.3M
Gates Foundation INV-017692NHLBI NIH HHS R01 HL130040NIA NIH HHS R01 AG017430
6 · The paper itself

Abstract

We developed an

Indexed as

gene therapyhelper-dependent adenovirus vectorhematopoietic stem cellsHMGA2insertion site analysisin vivoSleeping Beauty transposase

Identifiers

PMID39282078
PMCPMC11399618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.